Abstract
AbstractIn this mixed methods study, a survey and in-depth interviews were used to explore whether decision regret and the psychological impact of receiving genome sequencing (GS) results differed between parents and patients, and between those who received a genetic diagnosis and those who did not. Participants (n = 77) completed a survey that included the Decisional Regret Scale (DRS) and an adaptation of the Multidimensional Impact of Cancer Risk Assessment (MICRA) at least 12 months after consenting for GS for rare disease diagnosis in the 100,000 Genomes Project. Survey participants were invited to take part in an interview and 39 agreed; 12 with a diagnosis, 5 with variants of uncertain significance, and 19 with no pathogenic findings identified. Both survey and interview findings indicated that decision regret was low. DRS scores revealed no differences in levels of regret between parents and patients, or between those with a diagnosis and those without. Though MICRA scores indicated minimal evidence of negative psychological impacts of receiving GS results, subscale analysis revealed greater distress and uncertainty for parents compared to patients. Receiving a diagnosis was found not to influence MICRA scores, supporting interview findings of both positive and negative emotional and psychological impacts irrespective of a genetic diagnosis. Our findings have implications for policy and practice as GS is integrated into the UK and worldwide; notably, that expectation-setting is critical when offering GS, and that post-test counselling is important regardless of the GS result received, with parents perhaps needing additional emotional support.
Funder
DH | NIHR | Research for Patient Benefit Programme
NIHR Great Ormond Street Hospital (GOSH) Biomedical Research Centre
DH | NIHR | Public Health Research Programme
NIHR Great Ormond Street Hospital (GOSH) Biomedical Research Centre (BRC) NIHR Advanced Fellowship Grant
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference39 articles.
1. Griffin BH, Chitty LS, Bitner-Glindzicz M. The 100 000 Genomes Project: what it means for paediatrics. Arch Dis Child Educ Pr Ed. 2017;102:105–7.
2. Genetic Alliance UK. Genome sequencing and the NHS: the views of rare disease patients and carers. 2019.
3. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:2029–37.
4. Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19:253–68.
5. England G. The National Genomic Research Library v5.1: Amendment to The National Genomics Research and Healthcare Knowledgebase v5. Genomics England; 2020.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献